Mao Junfeng, Liu Shuangzhen
Department of Ophthalmology, Xiangya Hospital, Changsha, Hunan, China.
Department of Ophthalmology, Xiangya Hospital, Changsha, Hunan, China.
Neurosci Lett. 2017 Feb 3;639:94-97. doi: 10.1016/j.neulet.2016.12.061. Epub 2016 Dec 29.
To investigate whether the different role of ocular dopamine was involved in the myopic development between spontaneous myopia (SM) and form deprivation myopia (FDM) in albino guinea pigs.
55 myopic animals were randomly divided into SM, Levodapa (L-DOPA), L-DOPA+carbidopa and vehicle. 70 non-myopic animals were randomly divided into normal control, FDM, L-DOPA+FDM, L-DOPA+carbidopa+FDM and vehicle. Once per day, for 14days, L-DOPA (10mg/kg) was injected intraperitoneally, and carbidopa (1μg) was injected at the same time into the peribulbar space of the right eye. Refractive parameters and dopamine content in neural retina and RPE/choroid complex were measured.
In SM animals, high myopia was formed at 5 week of ages. L-DOPA treatment could reduce its myopic degree, and inhibit the increase of axial length and vitreous chamber depth with the increase of retinal dopamine in both eyes. Administration of carbidopa could prevent the increase of retinal dopamine induced by L-DOPA, but no influenced on its refractive state in the injected eyes. In non-SM animals, intraperitoneal L-DOPA could inhibit FDM, accompanied by the increase of retinal dopamine. Carbidopa treatment diminished the inhibition of FDM and prevented the increase in retinal dopamine by L-Dopa. Retinal dopamine was highly correlated with ocular refraction in FDM, but not in SM. There was no significant difference in dopamine content of RPE/choroid complex among all groups.
The role of retinal dopamine was different between SM and FDM in albino guinea pigs. Although systemic L-DOPA could inhibit the development of SM and FDM, retinal dopamine was only involved in the L-DOPA inhibition on FDM, but not on SM.
研究眼部多巴胺的不同作用是否参与白化豚鼠自发性近视(SM)和形觉剥夺性近视(FDM)的近视发展过程。
将55只近视动物随机分为SM组、左旋多巴(L-DOPA)组、L-DOPA+卡比多巴组和溶剂对照组。将70只非近视动物随机分为正常对照组、FDM组、L-DOPA+FDM组、L-DOPA+卡比多巴+FDM组和溶剂对照组。每天一次,连续14天,腹腔注射L-DOPA(10mg/kg),同时将卡比多巴(1μg)注射到右眼球周间隙。测量神经视网膜和视网膜色素上皮/脉络膜复合体中的屈光参数和多巴胺含量。
在SM动物中,5周龄时形成高度近视。L-DOPA治疗可降低其近视度数,并抑制双眼视网膜多巴胺增加时眼轴长度和玻璃体腔深度的增加。给予卡比多巴可防止L-DOPA诱导的视网膜多巴胺增加,但对注射眼的屈光状态无影响。在非SM动物中,腹腔注射L-DOPA可抑制FDM,同时视网膜多巴胺增加。卡比多巴治疗减弱了对FDM的抑制作用,并阻止了L-Dopa引起的视网膜多巴胺增加。视网膜多巴胺与FDM中的眼屈光高度相关,但与SM无关。所有组间视网膜色素上皮/脉络膜复合体的多巴胺含量无显著差异。
白化豚鼠中SM和FDM的视网膜多巴胺作用不同。虽然全身给予L-DOPA可抑制SM和FDM的发展,但视网膜多巴胺仅参与L-DOPA对FDM的抑制,而不参与对SM的抑制。